Gabapentinoids: Pregabalin and Gabapentin
A clinical reference on Pregabalin and Gabapentin, the rapidly emerging class of abused nerve-pain medications, covering their pharmacology and abuse patterns.
Part 5: Gabapentinoids — Pregabalin and Gabapentin
Clinical Reference for Healthcare Professionals.
1. Pregabalin
| Field | Detail |
|---|---|
| INN / Salt | Pregabalin |
| Drug Class | Gabapentinoid (Alpha-2-Delta Ligand) |
| Schedule | Schedule H1 (reclassified by CDSCO in 2025 following massive abuse) |
| Indian Brands | Pregastar, Lyrica, Pregalin, Pregaba, Nervigesic |
| Legitimate Uses | Neuropathic pain, epilepsy (adjunct), generalized anxiety disorder, fibromyalgia |
Mechanism of Action
Pregabalin binds with high affinity to the alpha-2-delta (α2δ) subunit of voltage-gated calcium channels in the CNS. This reduces the influx of calcium into presynaptic nerve terminals, decreasing the release of excitatory neurotransmitters (glutamate, noradrenaline, substance P). It has linear pharmacokinetics and approximately 90% bioavailability, making its effects highly predictable and potent. The exact mechanism producing euphoria is not fully understood but may involve indirect effects on the dopaminergic reward system.
Pharmacokinetics
| Parameter | Value |
|---|---|
| Bioavailability | ~90% (oral, dose-independent) |
| Onset of Action | 30-60 minutes |
| Peak Plasma | 1-1.5 hours |
| Half-Life | 5.5-6.7 hours |
| Metabolism | Negligible hepatic metabolism (excreted unchanged) |
| Excretion | Renal (>90% unchanged) |
| Protein Binding | None (0%) |
Why It Is Abused
Pregabalin produces a euphoria variously described as “floating,” “alcohol-like without the hangover,” or a “warm glow.” At supratherapeutic doses (3x to 20x the prescribed amount, i.e., 1,800-12,000 mg/day vs. therapeutic max of 600mg/day), it produces disinhibition, sociability, and a sense of well-being.
India-Specific Data: Punjab has been the epicenter of Pregabalin abuse in India. In 2024, law enforcement seized Pregabalin stocks worth crores of rupees from illicit distribution networks. The abuse is disproportionately high among individuals with existing opioid use disorders — they use Pregabalin to manage withdrawal symptoms or potentiate opioid effects. Following these enforcement actions and clinical reports, CDSCO placed Pregabalin under Schedule H1 in early 2026, mandating strict prescription records and 3-year retention of dispensing logs.
Side Effects & Dangers of Abuse
- Respiratory Depression: Significant when combined with opioids, benzodiazepines, or alcohol. This combination is a growing cause of overdose deaths globally.
- Severe Dizziness & Ataxia: High risk of falls and injuries.
- Suicidal Ideation: FDA warning for increased suicidal thoughts.
- Withdrawal Syndrome: Anxiety, insomnia, nausea, headache, diarrhea, and seizures (similar to benzodiazepine withdrawal).
- Weight Gain: Significant with chronic use.
Clinician Red Flags
- Patient requesting specific high-dose formulations (e.g., Pregabalin 300mg).
- Rapid dose escalation beyond standard therapeutic ranges (75-600mg/day).
- Combining Pregabalin prescriptions with opioid prescriptions from different doctors.
2. Gabapentin
| Field | Detail |
|---|---|
| INN / Salt | Gabapentin |
| Drug Class | Gabapentinoid (Alpha-2-Delta Ligand) |
| Schedule | Schedule H |
| Indian Brands | Gabapin, Neurontin, Gabator, Gabantin |
| Legitimate Uses | Neuropathic pain (post-herpetic neuralgia), epilepsy (adjunct), restless legs syndrome |
Mechanism of Action
Gabapentin shares the same alpha-2-delta calcium channel mechanism as Pregabalin. However, it has non-linear, saturable absorption kinetics — as the dose increases, the percentage absorbed decreases. This means at very high doses, increasing the amount taken does not proportionally increase the blood level, limiting its “ceiling” for abuse compared to Pregabalin.
Why It Is Abused
While less potent than Pregabalin, Gabapentin is still widely abused, particularly in opioid-dependent populations. It potentiates the effects of opioids and is used to intensify a heroin or oxycodone high. It also produces its own mild euphoria and relaxation at high doses.
Side Effects & Dangers of Abuse
- Potentiation of Opioid Overdose: The primary clinical danger. Gabapentin combined with opioids significantly increases the risk of fatal respiratory depression.
- Dizziness, Somnolence, Ataxia: Standard CNS depressant side effects.
- Peripheral Edema: Swelling of hands and feet.
- Withdrawal: Less severe than Pregabalin but includes anxiety, insomnia, and, rarely, seizures.
Clinician Red Flags
- Concurrent prescriptions for Gabapentin and opioids from separate providers.
- Requests for unusually high doses (e.g., 3600mg/day or more).
- Patient reports of Gabapentin “not working” — may indicate diversion or tolerance from recreational use.
Next: Part 6: Stimulants — Methylphenidate, Modafinil, Amphetamines
Comments
Recently Viewed
Related Posts
Part 51B: Jan Aushadhi MRP Guide — Gabapentinoids, Muscle Relaxants & Stimulants
A complete Jan Aushadhi (PMBJP) Maximum Retail Price reference for gabapentinoids (Pregabalin, Gabapentin), muscle relaxants (Baclofen, Tizanidine, Chlorzoxazone), and CNS stimulants/dissociatives (Modafinil, Dextromethorphan). Data verified May 2026.
Drugs of Abuse: A Clinical Reference Guide for Healthcare Professionals
An educational pharmacology reference cataloging prescription and OTC drugs commonly diverted for recreational misuse, organized by drug class with salt names, mechanisms, side effects, and Indian scheduling.
Opioids (Mild): Codeine, Tramadol, and Tapentadol
A clinical pharmacology reference on Codeine, Tramadol, and Tapentadol — their legitimate uses, mechanisms, why they are abused, side effects, and Indian scheduling.